Cargando…
Adherence to Antiretrovirals and HIV Viral Suppression Under COVID-19 Pandemic Interruption – Findings from a Randomized Clinical Trial Using Ingestible Sensors to Monitor Adherence
ABSTRACT: The COVID-19 pandemic had a significant impact on vulnerable populations, including people living with HIV. California implemented a coronavirus lockdown (stay-at-home order) in March 2020, which ended in January 2021. We evaluated the pandemic’s impact on both clinical outcomes of HIV RNA...
Autores principales: | Wang, Yan, Daar, Eric S., Huang, Yilan, Xiong, Di, Shen, Jie, Zhou, Linyu, Siqueiros, Lisa, Guerrero, Mario, Rosen, Marc I., Liu, Honghu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598162/ https://www.ncbi.nlm.nih.gov/pubmed/37401993 http://dx.doi.org/10.1007/s10461-023-04118-9 |
Ejemplares similares
-
Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial
por: Liu, Honghu, et al.
Publicado: (2022) -
Perceptions of People Living with HIV and HIV Healthcare Providers on Real-Time Measuring and Monitoring of Antiretroviral Adherence Using Ingestible Sensors: A Qualitative Study
por: Kamal, Susan, et al.
Publicado: (2020) -
Real‐Time and Wireless Assessment of Adherence to Antiretroviral Therapy With Co‐Encapsulated Ingestion Sensor in HIV‐Infected Patients: A Pilot Study
por: Daar, Eric S., et al.
Publicado: (2019) -
Influence of provider experience on antiretroviral adherence and viral suppression
por: Horberg, Michael A, et al.
Publicado: (2012) -
Feasibility of an Ingestible Sensor-Based System for Monitoring Adherence to Tuberculosis Therapy
por: Belknap, Robert, et al.
Publicado: (2013)